This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
dcterms	http://purl.org/dc/terms/
n9	http://localhost/temp/predkladatel/
n7	http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n6	http://linked.opendata.cz/ontology/domain/vavai/
n12	http://linked.opendata.cz/ontology/domain/vavai/riv/kodPristupu/
rdfs	http://www.w3.org/2000/01/rdf-schema#
n15	http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61989592%3A15110%2F08%3A00007485%21RIV09-MSM-15110___/
skos	http://www.w3.org/2004/02/skos/core#
n3	http://linked.opendata.cz/ontology/domain/vavai/riv/
n2	http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n5	http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n4	http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdh	http://www.w3.org/2001/XMLSchema#
n17	http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n11	http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n16	http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n14	http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n10	http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item

n2:RIV%2F61989592%3A15110%2F08%3A00007485%21RIV09-MSM-15110___

rdf:type

n6:Vysledek skos:Concept

rdfs:seeAlso

www.urol.cz

dcterms:description

Chemoprevence karcinomu prostaty Introduction: Prostate cancer is the most common tumor in the male population in Western Europe and USA. In the Czech Republic incidence is 96.87/100 000 inhabitants (NOR 2005). Prostate cancer is third most frequent causation of death for malignant tumor (28.52/1000 inhabitants). Prostate cancer chemoprevention can be described as the administration of natural products and pharmaceutical agents that inhibit one or more steps in the natural history of prostatic carcinogenesis. In recent, prostate carcinoma is the most common cancer in European and American men. Prostate cancer is an excellent target for chemoprevention strategies; given its late age of onset, any delay in carcinogenesis would lead to a reduction in its incidence. In 2003, the Prostate Cancer Prevention Trial (PCPT) became the first phase III clinical trial of prostate cancer prevention. This landmark study was terminated early due to the 24.8% reduction of prostate cancer prevalence over a 7-year period in those men t Introduction: Prostate cancer is the most common tumor in the male population in Western Europe and USA. In the Czech Republic incidence is 96.87/100 000 inhabitants (NOR 2005). Prostate cancer is third most frequent causation of death for malignant tumor (28.52/1000 inhabitants). Prostate cancer chemoprevention can be described as the administration of natural products and pharmaceutical agents that inhibit one or more steps in the natural history of prostatic carcinogenesis. In recent, prostate carcinoma is the most common cancer in European and American men. Prostate cancer is an excellent target for chemoprevention strategies; given its late age of onset, any delay in carcinogenesis would lead to a reduction in its incidence. In 2003, the Prostate Cancer Prevention Trial (PCPT) became the first phase III clinical trial of prostate cancer prevention. This landmark study was terminated early due to the 24.8% reduction of prostate cancer prevalence over a 7-year period in those men t

dcterms:title

CHEMOPREVENTION OF PROSTATE CARCINOMA CHEMOPREVENTION OF PROSTATE CARCINOMA Chemoprevence karcinomu prostaty

skos:prefLabel

Chemoprevence karcinomu prostaty CHEMOPREVENTION OF PROSTATE CARCINOMA CHEMOPREVENTION OF PROSTATE CARCINOMA

skos:notation

RIV/61989592:15110/08:00007485!RIV09-MSM-15110___

n3:aktivita

n17:S

n3:aktivity

S

n3:dodaniDat

n10:2009

n3:domaciTvurceVysledku

n7:3804763 n7:6047998 n7:1988697

n3:druhVysledku

n16:A

n3:duvernostUdaju

n4:S

n3:entitaPredkladatele

n15:predkladatel

n3:idSjednocenehoVysledku

359746

n3:idVysledku

RIV/61989592:15110/08:00007485

n3:jazykVysledku

n11:eng

n3:klicovaSlova

prostate carcinoma; chemoprevention

n3:klicoveSlovo

n5:prostate%20carcinoma n5:chemoprevention

n3:kodPristupu

n12:V

n3:kontrolniKodProRIV

[61CBCF4B5019]

n3:objednatelVyzkumneZpravy

Urologická klinika Olomouc

n3:obor

n14:FJ

n3:pocetDomacichTvurcuVysledku

3

n3:pocetTvurcuVysledku

4

n3:rokUplatneniVysledku

n10:2008

n3:tvurceVysledku

Hrabec, Martin Študent, Vladimír Vidlář, Aleš Vrtal, Radovan

n9:organizacniJednotka

15110